# Allarity Therapeutics, Inc.: filings

ALLR · Nasdaq · CIK 1860657 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/allr.md) · [Financials](/companies/allr/financials.md) · [Filings](/companies/allr/filings.md) · [Insiders](/companies/allr/insiders.md)

## Reports and events: 206 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 154, 424B3 22, 3 19, CORRESP 16, 10-Q 15, 4 15, 424B5 15, S-1/A 13, 425 11, EFFECT 11, UPLOAD 11, DEFA14A 9, DEF 14A 8, PRE 14A 7, S-4/A 7, SC 13G/A 7, D 6, S-3 6, SC 13G 6, 10-K 5, 8-K/A 5, 4/A 4, S-1 4, ARS 3, NT 10-Q 3, 424B4 2, RW 2, S-3/A 2, SEC STAFF LETTER 2, 10-K/A 1, 10-Q/A 1, 8-A12B 1, CERT 1, DEFR14A 1, DRS 1, NT 10-K 1, POS AM 1, PRER14A 1, S-4 1, S-8 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:05 ET | [8-K](/filings/0001213900-26-114380.md) | 1.02 Termination of a material agreement | 0001213900-26-114380 |
| 2026-10-01 | 08:00 ET | [8-K](/filings/0001213900-26-105457.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-105457 |
| 2026-09-29 | 08:00 ET | [8-K](/filings/0001213900-26-104317.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-104317 |
| 2026-09-16 | 08:00 ET | [8-K](/filings/0001213900-26-100350.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-100350 |
| 2026-09-14 | 12:14 ET | [8-K](/filings/0001213900-26-099576.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-099576 |
| 2026-08-14 | 16:35 ET | [8-K](/filings/0001213900-26-090183.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090183 |
| 2026-08-14 | 08:02 ET | [10-Q](/filings/0001437749-26-027830.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027830 |
| 2026-07-01 | 08:05 ET | [8-K](/filings/0001213900-26-073998.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-073998 |
| 2026-06-22 | 08:10 ET | [8-K](/filings/0001213900-26-070382.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-070382 |
| 2026-06-02 | 17:10 ET | [8-K](/filings/0001213900-26-064278.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-064278 |
| 2026-05-15 | 16:03 ET | [10-Q](/filings/0001437749-26-017371.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017371 |
| 2026-05-08 | 17:20 ET | [8-K](/filings/0001213900-26-054019.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-054019 |
| 2026-05-06 | 08:05 ET | [8-K](/filings/0001213900-26-052542.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-052542 |
| 2026-04-30 | 16:12 ET | [DEF 14A](/filings/0001213900-26-050231.md) | Proxy statement, period 2026-06-26 | 0001213900-26-050231 |
| 2026-04-28 | 08:03 ET | [8-K](/filings/0001213900-26-048277.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-048277 |
| 2026-04-22 | 08:15 ET | [8-K](/filings/0001213900-26-046411.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-046411 |
| 2026-04-01 | 08:54 ET | [8-K](/filings/0001213900-26-038061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-038061 |
| 2026-03-30 | 17:29 ET | [10-K](/filings/0001437749-26-010310.md) | Annual report, period 2025-12-31 | 0001437749-26-010310 |
| 2026-03-09 | 09:02 ET | [8-K](/filings/0001213900-26-024952.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-024952 |
| 2026-03-06 | 08:22 ET | [8-K](/filings/0001213900-26-024339.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-024339 |
| 2026-02-19 | 08:00 ET | [8-K](/filings/0001213900-26-018161.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-018161 |
| 2026-02-04 | 08:00 ET | [8-K](/filings/0001213900-26-011826.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-011826 |
| 2026-01-29 | 07:49 ET | [8-K](/filings/0001213900-26-009157.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-009157 |
| 2025-12-23 | 09:21 ET | [8-K](/filings/0001213900-25-124935.md) | 3.02 Unregistered sale of equity | 0001213900-25-124935 |
| 2025-12-08 | 09:16 ET | [8-K](/filings/0001213900-25-118989.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-118989 |
| 2025-11-14 | 09:00 ET | [10-Q](/filings/0001437749-25-035003.md) | Quarterly report, period 2025-09-30 | 0001437749-25-035003 |
| 2025-09-24 | 07:58 ET | [8-K](/filings/0001213900-25-090872.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-090872 |
| 2025-09-22 | 17:30 ET | [8-K](/filings/0001213900-25-090197.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-090197 |
| 2025-09-22 | 18:13 ET | [8-K](/filings/0001213900-25-089680.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-089680 |
| 2025-08-27 | 08:00 ET | [8-K](/filings/0001213900-25-080923.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-080923 |
| 2025-08-15 | 16:30 ET | [10-Q](/filings/0001437749-25-027146.md) | Quarterly report, period 2025-06-30 | 0001437749-25-027146 |
| 2025-07-16 | 07:20 ET | [8-K](/filings/0001213900-25-064456.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-064456 |
| 2025-07-07 | 08:43 ET | [8-K](/filings/0001213900-25-061639.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-061639 |
| 2025-07-01 | 16:05 ET | [8-K](/filings/0001213900-25-060366.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-060366 |
| 2025-06-30 | 08:00 ET | [8-K](/filings/0001437749-25-021482.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-021482 |
| 2025-06-17 | 16:21 ET | [8-K](/filings/0001437749-25-020652.md) | 5.07 Shareholder vote results | 0001437749-25-020652 |
| 2025-06-11 | 16:10 ET | [8-K](/filings/0001437749-25-020081.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-020081 |
| 2025-06-05 | 08:09 ET | [8-K](/filings/0001437749-25-019471.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-019471 |
| 2025-06-03 | 08:05 ET | [8-K](/filings/0001437749-25-019219.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-019219 |
| 2025-05-13 | 08:01 ET | [8-K](/filings/0001437749-25-016264.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-016264 |
| 2025-05-09 | 16:11 ET | [10-Q](/filings/0001437749-25-015780.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015780 |
| 2025-05-09 | 16:07 ET | [8-K](/filings/0001437749-25-015778.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-015778 |
| 2025-04-30 | 17:27 ET | [DEF 14A](/filings/0001437749-25-013914.md) | Proxy statement, period 2025-06-13 | 0001437749-25-013914 |
| 2025-04-28 | 08:01 ET | [8-K](/filings/0001437749-25-013236.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-013236 |
| 2025-04-16 | 16:11 ET | [8-K](/filings/0001437749-25-012153.md) | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list | 0001437749-25-012153 |
| 2025-03-31 | 16:16 ET | [10-K](/filings/0001437749-25-010198.md) | Annual report, period 2024-12-31 | 0001437749-25-010198 |
| 2025-03-31 | 16:10 ET | [8-K](/filings/0001437749-25-010187.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-010187 |
| 2025-03-25 | 16:06 ET | [8-K](/filings/0001437749-25-009132.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-009132 |
| 2025-03-18 | 08:01 ET | [8-K](/filings/0001437749-25-008139.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-008139 |
| 2025-03-14 | 08:01 ET | [8-K](/filings/0001437749-25-007620.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-007620 |

Page 1 of 5. [Older](/companies/allr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.